BRIEF-Epigenomics shares drop 47.1 pct after says FDA needs additional data on Epi proColon test

FRANKFURT, June 3 Tue Jun 3, 2014 3:08am EDT





FRANKFURT, June 3 (Reuters) - Epigenomics AG : * Shares drop 47.1 percent after says FDA needs additional data on epi procolon

via Smart Health Shop Forum http://ift.tt/1ud8JwZ